Poll shows doubt in pandemic response and care costs
Poll offers insight into public's view on the pandemic response and health care costs.
The pandemic has led to a lot of questions over how health care is done in the United States, the costs of health care, and many other elements of care. The monthly West Health-Gallup US Healthcare Study offers a chance to check the pulse on public sentiment and the most recent one shows that many Americans believe that the country is headed in the right direction. Just 8% of the respondents said they felt the country was going in the right direction for health care costs and 27% said that they felt the country’s pandemic management was good. It should be noted that the survey was performed before most of President Biden’s 100 day plans were known.
When the respondents were asked about the top concerns that they’d like the Biden administration to tackle in the first 100 days, they indicated lowering insurance premiums, cutting drug prices, and childcare for working parents. However, 49% of the respondents didn’t believe that the President and Congress would be able to achieve anything and 80% expected the costs to continue to rose over the next 2 years.
For more on the survey, check out our sister publication Medical Economics.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
